David Linetsky - Jan 6, 2022 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role
SVP, Life Sciences
Signature
/s/ Allison Hoffman by Power of Attorney for David Linetsky
Stock symbol
PHR
Transactions as of
Jan 6, 2022
Transactions value $
$164,659
Form type
4
Date filed
1/7/2022, 03:16 PM
Previous filing
Nov 9, 2021
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHR Common Stock Options Exercise $115K +24.3K +17.32% $4.71* 165K Jan 6, 2022 Direct F1
transaction PHR Common Stock Options Exercise $4.47K +948 +0.58% $4.71* 166K Jan 6, 2022 Direct F1
transaction PHR Common Stock Options Exercise $45.7K +5.69K +3.43% $8.03 171K Jan 6, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHR Stock Options (Right to buy) Options Exercise $0 -24.3K -81.04% $0.00 5.69K Jan 6, 2022 Common Stock 24.3K $4.71 Direct F2
transaction PHR Stock Options (Right to buy) Options Exercise $0 -948 -66.62% $0.00 475 Jan 6, 2022 Common Stock 948 $4.71 Direct F3
transaction PHR Stock Options (Right to buy) Options Exercise $0 -5.69K -50% $0.00 5.69K Jan 6, 2022 Common Stock 5.69K $8.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F3 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F4 25% of this option vested and became exercisable on January 17, 2020, with the remainder vesting in three (3) equal annual installments thereafter.